IGF-IR Antibodies

Santa Cruz Biotechnology provides a broad selection of IGF-IR monoclonal antibodies for various research applications. IGF-IR monoclonal antibodies are optimized for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Insulin-like Growth Factor I Receptor (IGF-IR) plays a crucial role in cell growth, differentiation, and survival, making it a significant target in cancer research and metabolic studies. The activation of IGF-IR is linked to various cellular processes, including the regulation of glucose metabolism and the promotion of cell proliferation. Understanding the function of IGF-IR is essential for developing therapeutic strategies against diseases associated with its dysregulation. IGF-IR monoclonal antibodies enable detailed investigation of signaling pathways and molecular mechanisms in both normal and pathological conditions. Researchers can effectively track IGF-IR expression patterns across different tissue types and experimental conditions. The high specificity of IGF-IR monoclonal antibodies supports precise detection and quantification in complex biological samples. Santa Cruz Biotechnology monoclonal antibodies for IGF-IR research contribute to advancing our understanding of cellular signaling and disease mechanisms.